NCT04813016View on ClinicalTrials.gov

Intraperitoneal Tramadol Versus Dexmedetomedine for Analgesia After Abdominal Laparoscopic Cancer Surgeries

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

May 1, 2022

Conditions
Analgesia
Interventions
DRUG

Tramal 1

Early intraperitoneal injection of tramal and bupivacaine

DRUG

Tramal 2

Late intraperitoneal injection of tramal and bupivacaine

DRUG

Dexmedetomidine 1

Early intraperitoneal injection of dexmedetomidine and bupivacaine

DRUG

dexmedetomidine 2

Late intraperitoneal injection of dexmedetomedine and bupivacaine

Trial Locations (1)

11796

National Cancer Institute, Cairo

All Listed Sponsors
lead

National Cancer Institute, Egypt

OTHER

NCT04813016 - Intraperitoneal Tramadol Versus Dexmedetomedine for Analgesia After Abdominal Laparoscopic Cancer Surgeries | Biotech Hunter | Biotech Hunter